PM
Prosight Management’s Cue Biopharma CUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,151,855
| Closed | -$4.11M | – | 38 |
|
|
2023
Q1 | $4.11M | Sell |
1,151,855
-688,655
| -37% | -$2.46M | 1.95% | 20 |
|
|
2022
Q4 | $5.25M | Buy |
1,840,510
+294,937
| +19% | +$841K | 2.86% | 13 |
|
|
2022
Q3 | $3.45M | Sell |
1,545,573
-109,904
| -7% | -$245K | 1.85% | 16 |
|
|
2022
Q2 | $4.12M | Buy |
1,655,477
+145,195
| +10% | +$362K | 3.25% | 12 |
|
|
2022
Q1 | $7.37M | Buy |
1,510,282
+681,240
| +82% | +$3.32M | 4.76% | 6 |
|
|
2021
Q4 | $9.38M | Buy |
829,042
+173,857
| +27% | +$1.97M | 5.61% | 4 |
|
|
2021
Q3 | $9.55M | Buy |
655,185
+24,821
| +4% | +$362K | 5.25% | 4 |
|
|
2021
Q2 | $7.34M | Buy |
630,364
+73,587
| +13% | +$857K | 4.59% | 5 |
|
|
2021
Q1 | $6.79M | Sell |
556,777
-349,792
| -39% | -$4.27M | 5.56% | 5 |
|
|
2020
Q4 | $11.3M | Buy |
906,569
+196,633
| +28% | +$2.46M | 5.24% | 4 |
|
|
2020
Q3 | $10.7M | Buy |
709,936
+399,642
| +129% | +$6.01M | 5.08% | 5 |
|
|
2020
Q2 | $7.61M | Sell |
310,294
-241,766
| -44% | -$5.93M | 3.26% | 9 |
|
|
2020
Q1 | $7.83M | Buy |
552,060
+414,432
| +301% | +$5.88M | 3.66% | 10 |
|
|
2019
Q4 | $2.19M | Buy |
+137,628
| New | +$2.19M | 0.96% | 28 |
|